Stoneridge Investment Partners LLC boosted its stake in Stericycle, Inc. (NASDAQ:SRCL) by 0.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 50,353 shares of the business services provider’s stock after buying an additional 45 shares during the period. Stoneridge Investment Partners LLC’s holdings in Stericycle were worth $3,843,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of SRCL. Eads & Heald Investment Counsel boosted its position in Stericycle by 24.9% in the first quarter. Eads & Heald Investment Counsel now owns 4,198 shares of the business services provider’s stock valued at $348,000 after buying an additional 836 shares in the last quarter. Silver Heights Capital Management Inc. boosted its position in Stericycle by 2.4% in the first quarter. Silver Heights Capital Management Inc. now owns 277,515 shares of the business services provider’s stock valued at $23,003,000 after buying an additional 6,490 shares in the last quarter. Capital Investment Services of America Inc. boosted its position in Stericycle by 3.5% in the second quarter. Capital Investment Services of America Inc. now owns 112,596 shares of the business services provider’s stock valued at $8,593,000 after buying an additional 3,825 shares in the last quarter. Smith Graham & Co. Investment Advisors LP boosted its position in Stericycle by 25.2% in the first quarter. Smith Graham & Co. Investment Advisors LP now owns 49,030 shares of the business services provider’s stock valued at $4,064,000 after buying an additional 9,870 shares in the last quarter. Finally, Vanguard Group Inc. boosted its position in Stericycle by 3.2% in the first quarter. Vanguard Group Inc. now owns 8,094,210 shares of the business services provider’s stock valued at $670,929,000 after buying an additional 251,061 shares in the last quarter. 95.16% of the stock is owned by hedge funds and other institutional investors.

Shares of Stericycle, Inc. (NASDAQ:SRCL) opened at 75.06 on Thursday. Stericycle, Inc. has a 52-week low of $71.52 and a 52-week high of $88.68. The firm has a market capitalization of $6.40 billion, a price-to-earnings ratio of 39.11 and a beta of 0.13. The stock has a 50 day moving average of $76.76 and a 200 day moving average of $80.57.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, August 3rd. The business services provider reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.13 by $0.02. Stericycle had a negative net margin of 0.07% and a positive return on equity of 14.35%. The company had revenue of $917.70 million for the quarter, compared to the consensus estimate of $902.81 million. During the same period in the previous year, the firm earned $1.18 EPS. Stericycle’s revenue was up 2.9% on a year-over-year basis. On average, analysts predict that Stericycle, Inc. will post $4.60 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This news story was published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/08/10/stoneridge-investment-partners-llc-has-3-84-million-stake-in-stericycle-inc-srcl.html.

Several research analysts have weighed in on SRCL shares. BidaskClub lowered shares of Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Deutsche Bank AG lowered their target price on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating on the stock in a research report on Monday, May 15th. Robert W. Baird lowered shares of Stericycle from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $74.00 to $73.00 in a research report on Friday, May 5th. Zacks Investment Research lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research report on Tuesday, May 2nd. Finally, Jefferies Group LLC restated a “buy” rating and set a $108.00 target price on shares of Stericycle in a research report on Thursday, July 13th. Four research analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $81.15.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.